RFC
CRL icon

Russell Frank Company’s Charles River Laboratories CRL Stock Holding History

Russell Frank Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$37.5M Buy
494,163
+33,899
+7% +$2.51M 0.07% 339
2015
Q4 		$37.1M Buy
460,264
+58,139
+14% +$4.19M 0.06% 321
2015
Q3 		$25.5M Buy
402,125
+47,316
+13% +$3.4M 0.05% 440
2015
Q2 		$25M Sell
354,809
-3,257
-0.9% -$241K 0.04% 522
2015
Q1 		$28.4M Sell
358,066
-7,046
-2% -$520K 0.05% 418
2014
Q4 		$23.4M Sell
365,112
-60,707
-14% -$3.81M 0.04% 509
2014
Q3 		$25.4M Sell
425,819
-2,490
-0.6% -$142K 0.05% 457
2014
Q2 		$22.9M Buy
428,309
+323,692
+309% +$17.8M 0.04% 509
2014
Q1 		$5.87M Buy
104,617
+88,439
+547% +$5.16M 0.01% 1200
2013
Q4 		$921K Buy
16,178
+5,394
+50% +$271K ﹤0.01% 2102
2013
Q3 		$499K Buy
10,784
+2,885
+37% +$132K ﹤0.01% 2492
2013
Q2 		$324K Buy
+7,899
New +$338K ﹤0.01% 2459

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Frank Company's CRL Position: Q1 2016 in Review

Russell Frank Company increased its Charles River Laboratories (CRL) stake by 7.4% in Q1 2016, buying an estimated $2.51M and bringing the position to 494,163 shares worth $37.5M. The position accounts for 0.07% of the portfolio, ranked #339.

Russell Frank Company first reported a position in CRL in Q2 2013 and has held it in 12 quarters since. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

  • Russell Frank Company held 494,163 shares of Charles River Laboratories worth $37.5M as of Q1 2016.
  • Russell Frank Company bought 33,899 Charles River Laboratories shares in Q1 2016, an estimated $2.51M.
  • Charles River Laboratories made up 0.07% of Russell Frank Company's portfolio in Q1 2016, its #339 holding.
  • Russell Frank Company first reported a position in Charles River Laboratories in Q2 2013 and has held it in 12 quarters since.
  • 264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.